National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 14019-14020 [2017-05193]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 50 / Thursday, March 16, 2017 / Notices
mstockstill on DSK3G9T082PROD with NOTICES
information about obligations and
prohibitions under Federal civil rights
laws at https://www.hhs.gov/ocr/aboutus/contact-us/headquarters-andregional-addresses/ or call 1–
800–368–1019 or TDD 1–800–537–7697.
Also note it is an HHS Departmental
goal to ensure access to quality,
culturally competent care, including
long-term services and supports, for
vulnerable populations. For further
guidance on providing culturally and
linguistically appropriate services,
recipients should review the National
Standards for Culturally and
Linguistically Appropriate Services in
Health and Health Care at https://
minorityhealth.hhs.gov/omh/
browse.aspx?lvl=2&lvlid=53.
Pursuant to 45 CFR 80.3(d), an
individual shall not be deemed
subjected to discrimination by reason of
his/her exclusion from benefits limited
by Federal law to individuals eligible
for benefits and services from the IHS.
Recipients will be required to sign the
HHS–690 Assurance of Compliance
form which can be obtained from the
following Web site: https://www.hhs.gov/
sites/default/files/forms/hhs-690.pdf,
and send it directly to the: U.S.
Department of Health and Human
Services, Office of Civil Rights, 200
Independence Ave. SW., Washington,
DC 20201.
E. Federal Awardee Performance and
Integrity Information System (FAPIIS)
The IHS is required to review and
consider any information about the
applicant that is in the Federal Awardee
Performance and Integrity Information
System (FAPIIS) before making any
award in excess of the simplified
acquisition threshold (currently
$150,000) over the period of
performance. An applicant may review
and comment on any information about
itself that a Federal awarding agency
previously entered. IHS will consider
any comments by the applicant, in
addition to other information in FAPIIS
in making a judgment about the
applicant’s integrity, business ethics,
and record of performance under
Federal awards when completing the
review of risk posed by applicants as
described in 45 CFR 75.205.
As required by 45 CFR part 75
Appendix XII of the Uniform Guidance,
non-federal entities (NFEs) are required
to disclose in FAPIIS any information
about criminal, civil, and administrative
proceedings, and/or affirm that there is
no new information to provide. This
applies to NFEs that receive Federal
awards (currently active grants,
cooperative agreements, and
procurement contracts) greater than
VerDate Sep<11>2014
17:12 Mar 15, 2017
Jkt 241001
$10,000,000 for any period of time
during the period of performance of an
award/project.
Mandatory Disclosure Requirements
As required by 2 CFR part 200 of the
Uniform Guidance, and the HHS
implementing regulations at 45 CFR part
75, effective January 1, 2016, the IHS
must require a non-federal entity or an
applicant for a Federal award to
disclose, in a timely manner, in writing
to the IHS or pass-through entity all
violations of Federal criminal law
involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award.
Submission is required for all
applicants and recipients, in writing, to
the IHS and to the HHS Office of
Inspector General all information
related to violations of Federal criminal
law involving fraud, bribery, or gratuity
violations potentially affecting the
Federal award. 45 CFR 75.113.
Disclosures must be sent in writing to:
U.S. Department of Health and Human
Services, Indian Health Service,
Division of Grants Management,
ATTN: Robert Tarwater, Director,
5600 Fishers Lane, Mail Stop: 09E70,
Rockville, Maryland 20857, (Include
‘‘Mandatory Grant Disclosures’’ in
subject line), Ofc: (301) 443–5204,
Fax: (301) 594–0899, Email:
Robert.Tarwater@ihs.gov.
AND
U.S. Department of Health and Human
Services, Office of Inspector General,
ATTN: Mandatory Grant Disclosures,
Intake Coordinator, 330 Independence
Avenue SW., Cohen Building, Room
5527, Washington, DC 20201, URL:
https://oig.hhs.gov/fraud/report-fraud/
index.asp, (Include ‘‘Mandatory Grant
Disclosures’’ in subject line), Fax:
(202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or
Email:
MandatoryGranteeDisclosures@
oig.hhs.gov.
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (See 2 CFR
parts 180 & 376 and 31 U.S.C. 3321).
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: Ms. Tina Tah,
RN/BSN/MBA, Project Official/Indian
Health Service, 5600 Fishers Lane,
Rockville, MD 20857, Phone: (301) 443–
0038, Fax: (301) 594–6213, E-Mail:
Tina.tah@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
14019
to:Vanietta Armstrong, Grants
Management Specialist, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville, MD
20857, Phone: (301) 443–4792, Fax:
(301) 594–0899, E-Mail:
Vanietta.Armstrong@ihs.gov.
3. Questions on systems matters may
be directed to: Paul Gettys, Grant
Systems Coordinator, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville, MD
20857, Phone: (301) 443–2114; or the
DGM main line (301) 443–5204, Fax:
(301) 594–0899, E-Mail: Paul.Gettys@
ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all cooperative agreement
and contract recipients to provide a
smoke-free workplace and promote the
non-use of all tobacco products. In
addition, Pub. L. 103–227, the ProChildren Act of 1994, prohibits smoking
in certain facilities (or in some cases,
any portion of the facility) in which
regular or routine education, library,
day care, health care, or early childhood
development services are provided to
children. This is consistent with the
HHS mission to protect and advance the
physical and mental health of the
American people.
Dated: March 6, 2017.
Chris Buchanan,
Assistant Surgeon General, USPHS, Acting
Director, Indian Health Service.
[FR Doc. 2017–05248 Filed 3–15–17; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
E:\FR\FM\16MRN1.SGM
16MRN1
14020
Federal Register / Vol. 82, No. 50 / Thursday, March 16, 2017 / Notices
Date: April 10, 2017.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Brenda Lange-Gustafson,
Ph.D., Scientific Review Officer, NIAID/NIH/
DHHS, Scientific Review Program, 5601
Fishers Lane, Room 3G13, Rockville, MD
20852, 240–669–5047, bgustafson@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7182, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7182, Bethesda, MD 20892, 301–
827–7987, susan.sunnarborg@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS
[FR Doc. 2017–05193 Filed 3–15–17; 8:45 am]
Dated: March 13, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2017–05280 Filed 3–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Conference Grant Review (R13).
Date: April 4, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7184, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: YingYing Li-Smerin, MD,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7184, Bethesda, MD 20892–
7924, 301–827–7942, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Loan Repayment Program.
Date: April 4, 2017.
VerDate Sep<11>2014
17:12 Mar 15, 2017
Jkt 241001
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
16–022: Novel and Innovative Tools to
Facilitate Identification, Tracking,
Manipulation, and Analysis of Glycans and
their Functions (U01).
Date: April 11, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Vonda K Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6188,
MSC 7892, Bethesda, MD 20892, 301–435–
1789, smithvo@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
16–023: Innovative Adaptations to Simplify
Existing Technologies for Manipulation and
Analysis of Glycans (U01).
Date: April 11, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Vonda K Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6188,
MSC 7892, Bethesda, MD 20892, 301–435–
1789, smithvo@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA CA16–
020: BD2K Support for Meetings.
Date: April 12, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Craig Giroux, Ph.D.,
Scientific Review Officer, BST IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–05282 Filed 3–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 82, Number 50 (Thursday, March 16, 2017)]
[Notices]
[Pages 14019-14020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05193]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
[[Page 14020]]
Date: April 10, 2017.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Brenda Lange-Gustafson, Ph.D., Scientific Review
Officer, NIAID/NIH/DHHS, Scientific Review Program, 5601 Fishers
Lane, Room 3G13, Rockville, MD 20852, 240-669-5047,
bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-05193 Filed 3-15-17; 8:45 am]
BILLING CODE 4140-01-P
